Efficacy and Safety Study of Mizoribine in Active Rheumatoid (AMOLED)

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2013
The purpose of this study is to access the efficacy and safety of Mizoribine 150mg qid and 50mg tid in active rheumatoid arthritis patients unsuccessfully treated with disease-modifying antirheumatic drug.
Epistemonikos ID: 3c1e9b0bb48fc7cc8369555743e00538f378555a
First added on: Mar 23, 2022